EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark ConjuAll was filed as Word mark on 12/23/2021 at the European Union Intellectual Property Office.
It was registered as a trademark on 05/31/2022.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018627367 |
| Application date | December 23, 2021 |
| Publication date | February 21, 2022 |
| Entry date | May 31, 2022 |
| Expiration date | December 23, 2031 |
Trademark owner
8-26, Munpyeongseo-ro, Daedeok-gu
34302 Daejeon
KR
34302 Daejeon
KR
Trademark representatives
Avenida Fotógrafo Francisco Cano 91A
03540 Alicante
ES
goods and services
5
Medical preparations, especially antibodies, antibody conjugates and active ingredients and antibody conjugates; chemical reagents for medical use, especially chemical reagents for linking molecules for medical use; antibodies and the chemical modifications and conjugates thereof for medical purposes and medical laboratory tests; drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; biological preparations for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical pharmaceuticals for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical molecular diagnostic reagents for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; biopharmaceuticals for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; pharmaceutical preparations for treatment of rare diseases
42
Research on the subject of pharmaceuticals; development of pharmaceutical preparations and medicines; medical and pharmaceutical research services; biological research and analysis; chemical research and analysis; biochemical research and analysis; clinical trials
ID: 11018627367